Skip to content

Acupuncture Treatment for Irritable Bowel Syndrome: A Double-Blind Controlled Study

Fireman et al. · Digestion · 2001

🔬Double-Blind RCT👥n = 25📊Moderate Evidence

Evidence Level

MODERATE
60/ 100
Quality
3/5
Sample
2/5
Replication
1/5
🎯

OBJECTIVE

To assess whether true acupuncture is more effective than sham acupuncture for treating irritable bowel syndrome

👥

WHO

25 patients with irritable bowel syndrome of more than 1 year's duration

⏱️

DURATION

4 weeks with four 30-minute sessions

📍

POINTS

LI-4 (Large Intestine) for true acupuncture and BL-60 (Bladder) for sham

🔬 Study Design

25participants
randomization

True acupuncture

n=25

Needling at point LI-4

Sham acupuncture

n=25

Needling at point BL-60

⏱️ Duration: 4 weeks with a 3-week interval between treatments

📊 Results in numbers

p = 0.05

Overall improvement after 1st session

p = 0.04

Improvement of abdominal pain

p = 0.027

Alternating diarrhea/constipation

0%

Dropout rate

Percentage highlights

22%
Dropout rate

📊 Outcome Comparison

Overall well-being (1st session)

True acupuncture
4.1
Sham acupuncture
3.62

Abdominal pain (2nd session)

True acupuncture
4.11
Sham acupuncture
3.81
💬 What does this mean for you?

This study investigated whether acupuncture can help people with irritable bowel syndrome. Although it showed some temporary improvements in pain and overall well-being, the results were not consistent enough to demonstrate that acupuncture is more effective than a placebo treatment.

📝

Article summary

Plain-language narrative summary

Irritable bowel syndrome (IBS) is a functional condition that affects approximately 15% of the population, especially adults between 30 and 50 years of age, characterized by abdominal pain, altered bowel habits, and discomfort without an identifiable organic cause. Despite its high prevalence, therapeutic options remain limited and only modestly effective, motivating the search for alternative treatments such as acupuncture. This pioneering study, conducted in Israel between January and June 1999, represents the first double-blind controlled investigation of acupuncture in the treatment of IBS. Researchers recruited patients through gastroenterologists in the region, including those who met the 1990 Rome criteria and had presented symptoms for at least one year.

After rigorous assessment to exclude organic disease, 25 patients completed the study protocol. The methodology used a crossover design in which each participant received both true and sham acupuncture at different time points, serving as their own control. True acupuncture was applied at LI-4 (Large Intestine meridian), located between the first and second digits in the metacarpal region, while sham acupuncture used point BL-60 (Bladder meridian) in the paravertebral region at the level of T-6. Each treatment consisted of two 30-minute sessions over 4 weeks, with a 3-week washout period between the different types of acupuncture to eliminate residual effects.

Outcomes were assessed through weekly questionnaires using a 1-to-5 visual analog scale, in which patients rated changes in eight different symptoms. The findings revealed some statistically significant but limited improvements. After the first session of true acupuncture, there was a significant improvement in overall well-being (p = 0.05) and reduction of abdominal pain (p = 0.04 in the second session). Patients with alternating diarrhea and constipation also showed significant improvement (p = 0.027) after the first true session.

However, these effects were not consistently maintained over the course of treatment. Acupuncture did not demonstrate significant benefits for abdominal distension, discomfort relieved by defecation, or presence of mucus in stool. The mechanism proposed by the authors is based on the visceral hyperalgesia theory, suggesting that acupuncture could influence the visceral sensory system through stimulation of the somatic sensory system. The release of endogenous opioid peptides, such as endorphins and enkephalins, was also considered as a possible explanation for the analgesic effects observed.

Although results from true acupuncture were consistently superior to sham, the global statistical analysis did not demonstrate significant differences between groups. The clinical implications of this study are limited because of the small sample size and inconsistent results. The authors acknowledge that despite the punctual positive effects observed, it was not possible to establish a clear therapeutic benefit of acupuncture for IBS. This conclusion led them to question the rationale for investments in larger studies on this therapeutic approach.

The study has important limitations, including the small sample size, high dropout rate (22%), and lack of long-term follow-up. Furthermore, the use of different acupuncture points for true and sham treatment may have influenced the results, since both points could have distinct physiological effects.

Strengths

  • 1First double-blind controlled study on acupuncture in IBS
  • 2Crossover design with each patient serving as their own control
  • 3Rigorous evaluation to exclude organic causes
  • 4Use of a visual analog scale for objective measurement
⚠️

Limitations

  • 1Very small sample size (n = 25)
  • 2High dropout rate (22%)
  • 3Inconsistent results between sessions
  • 4Lack of long-term follow-up
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Irritable bowel syndrome affects about 15% of the population and represents one of the most frustrating functional diagnoses for both patient and attending physician. The conventional therapeutic arsenal — antispasmodics, motility modulators, low-dose antidepressants — frequently offers only partial and intermittent relief, which fully justifies investigating complementary approaches. This work, published in 2001 by Fireman's group, has undeniable historical value for being the first double-blind controlled trial to test acupuncture specifically in IBS. For the clinician who sees patients refractory to conventional treatments, particularly those with the mixed diarrhea-constipation subtype, the early signs of improvement observed after the first session with LI-4 are clinically relevant and justify including acupuncture in the integrated treatment plan, especially in patients with a high component of visceral hypersensitivity.

Notable Findings

The most noteworthy finding in this study is the early and selective response to point LI-4: a statistically significant improvement in overall well-being already after the first session (p = 0.05) and a reduction in abdominal pain at the second session (p = 0.04). The subgroup with alternating diarrhea-constipation showed the most robust signal (p = 0.027), suggesting that this clinical phenotype may be the best responder to somatic stimulation of the Large Intestine meridian. From a mechanistic perspective, the study embraces the visceral hyperalgesia theory — acupuncture would act by modulating the visceral sensory system via somatic stimulation, with probable mediation by endogenous opioid peptides such as endorphins and enkephalins. This hypothesis is consistent with what has been accumulated in pain neuroscience over recent decades and provides a solid pathophysiological basis for choosing point LI-4 for painful abdominal conditions.

From My Experience

In my practice with IBS patients at the HC-FMUSP Pain Center, I usually observe initial symptomatic response between the second and fourth sessions, which is consistent with the early signal reported by Fireman and colleagues. For these patients, I typically work with a protocol of eight to twelve sessions in the acute phase, combining LI-4 with ST-36, ST-25, and PC-6, depending on the predominance of pain or motor dysfunction. Combining this with stress management — whether through relaxation techniques or cognitive behavioral therapy — visibly amplifies the results, as the autonomic component in IBS is decisive. The patient profile that benefits most, in my experience, is exactly the mixed subtype this study identified as a responder: adults between 30 and 50 years of age, with a history of symptoms for more than one year and low tolerance to medications. Patients with strong overlapping severe anxiety tend to require more sessions before showing consistent stabilization.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Indexed scientific article

This study is indexed in an international scientific database. Check your institutional access to obtain the full article.

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.